Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
David MaahsDavid S Schade

Abstract

To evaluate the efficacy of orlistat to enhance weight loss in obese adolescents. The study was a 6-month randomized, double-blind, placebo-controlled trial to compare the effects of orlistat (120 mg orally 3 times a day) and placebo on reduction of body mass index (BMI). Forty adolescents between 14 and 18 years of age with a mean BMI of 40 kg/m2 entered the protocol between December 2002 and February 2003. Study subjects stayed overnight in the General Clinical Research Center, during which dietary records were reviewed and lifestyle recommendations were given. The study participants received either orlistat (120 mg orally 3 times a day) or placebo and were assessed monthly for 6 months. At 0, 3, and 6 months, fasting laboratory tests were performed. The primary end point was the change in BMI from baseline to 6 months. Secondary outcomes included changes in weight, lean body mass, and results of blood chemistry studies. No statistically significant difference was noted between the 2 study groups for decrease in BMI from baseline to 6 months (P = 0.39). The decrease in BMI within the orlistat group (-1.3 +/- 1.6 kg/m2; P = 0.04) and within the placebo group (-0.8 +/- 3.0 kg/m2; P = 0.02), however, was statistically significan...Continue Reading

References

Dec 31, 1997·Obesity Research·R L KolotkinA Brookhart
Jan 26, 1999·JAMA : the Journal of the American Medical Association·M H DavidsonS B Heymsfield
Aug 17, 1999·Medicine and Science in Sports and Exercise·W C Miller
Jul 10, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·H CavaliereG Medeiros-Neto
Jul 24, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·U Ravens-SiebererM Bullinger
Sep 15, 2001·Obesity Research·R L KolotkinS Nicol
Jul 10, 2002·Obesity Research·Jennifer R McDuffieJack A Yanovski
Jul 20, 2002·Pharmacotherapy·Jennifer R McDuffieJack A Yanovski
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Cynthia L OgdenClifford L Johnson
Apr 10, 2003·JAMA : the Journal of the American Medical Association·Jeffrey B SchwimmerJames W Varni
Aug 15, 2003·The Cochrane Database of Systematic Reviews·C D SummerbellE Waters
Oct 9, 2003·JAMA : the Journal of the American Medical Association·K M Venkat NarayanDavid F Williamson
Dec 4, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·D Jolliffe
Feb 19, 2004·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·S O'MearaG ter Riet
Jun 16, 2005·JAMA : the Journal of the American Medical Association·Jean-Pierre ChanoineJonathan Hauptman

❮ Previous
Next ❯

Citations

Aug 19, 2009·Reviews in Endocrine & Metabolic Disorders·Abigail B Wald, Naveen K Uli
Mar 12, 2013·Current Hypertension Reports·Susan M Halbach, Joseph Flynn
Aug 30, 2012·International Journal of Obesity : Journal of the International Association for the Study of Obesity·R Sherafat-KazemzadehJ A Yanovski
Oct 6, 2011·Nature Reviews. Gastroenterology & Hepatology·Louise A BaurVanessa A Shrewsbury
Apr 17, 2008·Harvard Review of Psychiatry·Michelle C AcostaFrances R Levin
Oct 1, 2010·Diabetes, Obesity & Metabolism·C Hearnshaw, K Matyka
Mar 12, 2013·Archives of Disease in Childhood. Education and Practice Edition·Razia Petkar, Neil Wright
Jan 1, 2009·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Amy Fleischman, Erinn T Rhodes
Jun 2, 2011·Journal of Clinical Medicine Research·Amar Kanekar, Manoj Sharma
May 4, 2011·World Journal of Diabetes·Ming-Fang Li, Bernard My Cheung
Mar 26, 2014·International Journal of Obesity : Journal of the International Association for the Study of Obesity·P T KatzmarzykJ A Yanovski
Sep 11, 2014·Current Treatment Options in Cardiovascular Medicine·Jackson H CoppockDenise E Wilfley
Nov 2, 2007·European Journal of Pediatrics·Margarita D TsirosJonathan D Buckley
Dec 10, 2009·Expert Opinion on Drug Safety·Katie S McClendonGabriel Ikponmosa Uwaifo
Oct 21, 2010·Expert Opinion on Pharmacotherapy·Natalia CatoiraClaudio D Gonzalez
May 19, 2012·The Canadian Journal of Cardiology·Thang Nguyen, David C W Lau
May 24, 2011·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·G A Martos-Moreno, J Argente
May 28, 2011·Primary Care Diabetes·Melissa Scollan-Koliopoulos, Bleich David
Feb 2, 2011·Pediatric Clinics of North America·Donald E GreydanusCynthia Feucht
Oct 13, 2010·Cardiology Clinics·Rae-Ellen W KaveyJoseph T Flynn
Oct 3, 2007·Mayo Clinic Proceedings·Vibha SinghalSeema Kumar
May 15, 2007·Gastroenterology·George A Bray, Donna H Ryan
Nov 20, 2009·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·R M VinerI C K Wong
Jun 9, 2011·Journal of the American Academy of Nurse Practitioners·Kristy F HopkinsLydia Elliott
Jun 6, 2013·Journal of Paediatrics and Child Health·Clare C W YuAlison M McManus
Dec 17, 2009·British Journal of Clinical Pharmacology·Mingfang Li, Bernard M Y Cheung
Jul 4, 2009·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·S CzernichowR R Huxley
Jun 26, 2014·Obesity·Eric A Finkelstein, Eliza Kruger
Mar 1, 2012·Orvosi hetilap·Gábor SimonyiJ Róbert Bedros
Apr 27, 2016·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A S KellyJ R Ryder
Nov 5, 2014·The Annals of Pharmacotherapy·Cassie L BolandKira B Harris
May 26, 2009·Arquivos brasileiros de endocrinologia e metabologia·Amélio F De Godoy-MatosMariana Farage Martins
Jul 27, 2007·The Annals of Pharmacotherapy·Kaelen C DunicanJulie K Montalbano
Jun 25, 2017·Current Diabetes Reports·Aaron S Kelly, Claudia K Fox
Feb 8, 2018·Expert Opinion on Drug Safety·Ariana M ChaoRobert I Berkowitz
Aug 13, 2014·Therapeutic Advances in Drug Safety·Bernard Man Yung CheungNithushi Rajitha Samaranayake
Nov 30, 2016·The Cochrane Database of Systematic Reviews·Emma MeadLouisa J Ells
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Hiltje Oude LuttikhuisCarolyn D Summerbell
Sep 11, 2013·Circulation·Aaron S KellyUNKNOWN American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascula
Jan 27, 2007·Stroke; a Journal of Cerebral Circulation·Nerses SanossianBruce Ovbiagele

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.